UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) May 19, 2011
SPECTRUMDNA, INC.
(Exact name of registrant as specified in its charter)
Commission file number 333-148883
|
Delaware
|
20-4880377
|
|
(State or other jurisdiction
|
(I.R.S. Employer
|
|
of incorporation or
|
Identification No.)
|
|
organization)
|
|
|
1781 Sidewinder Drive, Suite 201
|
|
|
P.O. Box 682798
|
|
|
Park City, Utah
|
84068
|
|
(Address of principal
|
(Zip Code)
|
|
executive offices)
|
Registrant’s telephone number, including area code: (435) 658-1349
Not applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
|
o
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
o
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
o
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
o
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
|
Item 8.01
|
Other Events.
|
Management of SpectrumDNA, Inc. (referred to herein as the “Company”, “we” and “our”) has noted a recent substantial increase in trading activity of its common stock. While we are optimistic about our future, with the Company having gained traction in 2011 due to the execution of its business operating strategy in the gamification space resulting in it achieving its best results since inception in the first quarter of 2011, we cannot explain the somewhat erratic and inconsistent market trading activity.
We have become aware of certain recent reports and information being produced and disseminated by parties unrelated to the Company. These reports were not sanctioned by the Company and were produced without the involvement, knowledge, consent or participation by the Company, our senior management or the Board of Directors. Neither the senior management nor the Board of Directors of the Company commissioned, authorized, or paid any stock promoter or any other third party for the production or dissemination of the aforementioned information on the Company’s behalf.
When used in this report, the words “may,” “will,” “expect,” “anticipate,” “continue,” “estimate,” “intend,” “plans”, and similar expressions are intended to identify forward-looking statements regarding events, conditions and financial trends which may affect our future plans of operations, business strategy, operating results and financial position. Forward looking statements in this report include without limitation statements relating to trends affecting our financial condition or results of operations, our business and growth strategies and our financing plans. Such statements are not guarantees of future performance and are subject to risks and uncertainties and actual results may differ materially from those included within the forward-looking statements as a result of various factors. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. We undertake no obligation to publicly release the result of any revision of these forward-looking statements to reflect events or circumstances after the date they are made or to reflect the occurrence of unanticipated events.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
SPECTRUMDNA, INC.
(Registrant)
|
|||
|
Dated: May 19, 2011
|
By:
|
/s/ James A. Banister | |
|
James A. Banister,
|
|||
|
Chief Executive Officer
|
|||
3